A Glycemic Control Evaluation of Glimepiride Versus Rimonabant on Top of Metformin in Type 2 Diabetes

Stopped Company decision taken in light of demands by certain national health authorities

Conditions

• Diabetes Mellitus, Type 2

Interventions

• DRUG: Rimonabant
• DRUG: Glimepiride
• DRUG: Metformin

Sponsor

Sanofi